Mice with adipocyte‐specific deletion of Mettl14 are resistant to HFD‐induced obesity, insulin resistance, glucose intolerance, and nonalcoholic fatty liver disease (NAFLD). Here, METTL14 is linked to metabolic dysfunction-associated steatotic liver disease.